Article Details

Triplet Therapeutics launches with $59 million to develop antisense therapies for Huntington's and ...

Retrieved on: 2020-01-03 05:56:15

Tags for this article:

Click the tags to see associated articles and topics

Triplet Therapeutics launches with $59 million to develop antisense therapies for Huntington's and .... View article details on hiswai:

Excerpt

<div>The company last month announced a $10 million seed investment from <b>Atlas</b> <b>Venture</b> and $49 million in series A financing led by MPM Capital and ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up